- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06651840
Coblation Versus Bipolar Diathermy in Management of Refractory Idiopathic Recurrent Anterior Epistaxis in Children.
Comparison Between Coblation Versus Bipolar Diathermy in Management of Refractory Idiopathic Recurrent Anterior Epistaxis in Children.
The aim of this study is to compare the outcomes of coblation technique versus bipolar technique in management of RAE in children regarding the following:
- Efficacy of each method to stop bleeding.
- Technical feasibility.
- Mucosal healing and crust formation.
- Post operative complications like: synechia formation and septal perforation.
- Nostril stenosis/ atresia.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Abanoub H Mejalli
- Phone Number: 01288547168
- Email: abanobhosni@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- A history of repeated unilateral epistaxis with at least four episodes, at least one episode per week during the preceding 4 weeks.
- Age > 5 years of age and < 18 years of age.
- Failure of topical treatment with an antiseptic ointment, with or without silver nitrate cautery.
- A Katsanis epistaxis scoring system (ESS) score of 7-10.
- Bleeding originating from Kiesselbach's plexus, located in the anteroinferior portion of the nasal septum.
Exclusion Criteria:
- Patients < 5 years of age and >= 18 years of age.
- Patients with bilateral epistaxis.
- Patients with bleeding tendencies like: Hemophilia, Leukemia, Idiopathic thrombocytopenic purpura, Von Willebrand disease and Thrombasthenia.
- Patients with previous nasal surgeries.
- Patients with hereditary hemorrhagic telangiectasia.
- Patients with vascular lesions like: angiofibroma, pyogenic granuloma and bleeding polypus.
- Patients who are unfit for surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group A: patients in this group will be managed with bipolar diathermy "Standard technique".
The bipolar technique for group A: A bipolar with straight blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively. |
The bipolar technique for group A: A bipolar with straight blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively. |
|
Experimental: Group B: patients in this group will be managed with coblation technique.
The coblation technique for group B: An coblator with tonsillar blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively. |
The coblation technique for group B: An coblator with tonsillar blade will be used with a footplate-operated switch to control the coagulation time, and the length, width and depth of penetration of the thermal power. The lesion will be coagulated in a distal-to-proximal direction to achieve a uniform gray-white coagulation zone in the lesion and surrounding tissue. Multiple ablations at the same area should be avoided to avoid septal perforation. After finishing coagulation small gauze impregnated with antibiotic ointment will be applied for 2 hours postoperatively. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with successful hemostasis on the day of the procedure.
Time Frame: The first 24 hours postoperative
|
No epistaxis within the first 24 hours of the procedure.
|
The first 24 hours postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative complications
Time Frame: 6 months
|
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Aly R Selim, Professor, PROFESSOR
- Study Director: Shimaa I Abdallah, Ass.Prof, Assistant Professor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Coblation in child's epistaxis
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epistaxis Nosebleed
-
Sheikh Zayed Federal Postgraduate Medical InstituteNot yet recruitingEpistaxis Nosebleed | Greater Palatine Foramen
-
Dr. Anne ConlinUniversity of OttawaRecruitingEpistaxis NosebleedCanada
-
Ankara Ataturk Sanatorium Training and Research...Not yet recruitingEpistaxis Nosebleed
-
NasaClipEmergency Medical Innovations, LLCRecruiting
-
University of ZurichCompletedNosebleed (Epistaxis) - Posterior or AnteriorSwitzerland
-
Bezmialem Vakif UniversityCompleted
-
Saglik Bilimleri UniversitesiAnkara Etlik City HospitalRecruitingEpistaxis Nosebleed | Atmospheric Pressure; Adverse EffectTurkey
-
Unity Health TorontoUnited States Department of DefenseCompletedHereditary Hemorrhagic Telangiectasia | Epistaxis NosebleedCanada
-
Youssef ZakiFaculty of Medicine , Kafrelshiekh University, Egypt.Completed
-
Izmir Ataturk Training and Research HospitalCompletedTranexamic Acid | Anterior EpistaxisTurkey
Clinical Trials on bipolar diathermy "Standard technique".
-
Mansoura UniversityCompletedProstate Hypertrophy | Holmium Laser | Thulium Laser | Bipolar Diathermy | Prostate EnucleationEgypt
-
Assiut UniversityNot yet recruitingLaparoscopic Appendectomy | Bipolar Diathermy
-
Chinese University of Hong KongUnknownUrinary Bladder TumorHong Kong
-
Hospices Civils de LyonCompleted
-
Chinese University of Hong KongThe University of Hong Kong; Queen Elizabeth Hospital, Hong Kong; North District... and other collaboratorsCompleted
-
Hospital de Concentracion Norte de PetroleosCompletedAbdominal Hysterectomy for Benign DiseaseMexico
-
IRCCS San RaffaeleNot yet recruitingPelvic Organ Prolapse | Surgery | Gynecologic DisordersItaly
-
Beni-Suef UniversityRecruitingLower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Benign Prostatic ObstructionEgypt
-
RESnTEC, Institute of ResearchCompleted